Hydroxypyridoxazepines used as NRF2 activators

MA54939AUndetermined Publication Date: 2021-12-22GLAXOSMITHKLINE INTPROP DEV LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA54939
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-11-07
Filing Date
2020-02-11
Publication Date
2021-12-22
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.